Jefferies and Barclays are joint bookrunners; co-manager BTIG assists
By Devika Patel
Knoxville, Tenn., April 25 - Lombard Medical, Inc. said it priced a $55 million initial public offering of stock with an $8.25 million greenshoe. The deal was announced April 23.
The company will sell 5 million ordinary shares at $11.00 per share.
Jefferies LLC and Barclays are the joint bookrunning managers.
Proceeds will be used to increase the company's sales force, develop a thoracic stent-graft system and for working capital and general corporate purposes.
The medical technology company is based in Oxfordshire, United Kingdom. The company intends to list its common stock on the Nasdaq stock exchange under the symbol "EVAR."
| Issuer: | Lombard Medical, Inc.
|
| Issue: | Ordinary stock
|
| Amount: | $55 million
|
| Greenshoe: | $8.25 million
|
| Shares: | 5 million
|
| Price: | $11.00
|
| Warrants: | No
|
| Bookrunners: | Jefferies LLC and Barclays
|
| Co-manager: | BTIG, LLC
|
| Announcement date: | April 23
|
| Pricing date: | April 25
|
| Stock exchange: | Nasdaq: EVAR
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
